Ypsomed Holding AG
YPSN
Rank in Stocks
#2948
Ypsomed Holding AG, together with its subsidiaries, develops, manufactures, and... Ypsomed Holding AG, together with its subsidiaries, develops, manufactures, and sells injection and infusion systems for safe and simple self-medication companies. The company operates through three segments: Ypsomed Delivery Systems, Ypsomed Diabetes Care, and Others. The Ypsomed Delivery Systems segment provides various injection systems, such as pen injectors, auto-injectors, and wearable injectors, as well as other smart devices. This segment offers its products under the YDS brand. The Ypsomed Diabetes Care segment sells and trades in insulin pumps, infusion sets, pen needles, blood glucose monitoring systems, accessories, and other day-to-day items for diabetics. This segment offers its products under the mylife brand name. The company offers precision turned parts; and contract manufacturing and other services. It markets its products through pharmaceutical partners, as well as through its own distribution network and independent distributors. It operates in Switzerland, Europe, North America, and internationally. Ypsomed Holding AG was founded in 1984 and is headquartered in Burgdorf, Switzerland.
Share Price
$469.39
Market Cap
$6.17B
Change (1 day)
1.63%
Change (1 year)
18.98%
Country
CH
Trade Ypsomed Holding AG (YPSN)
Category
Healthcare
P/B ratio for Ypsomed Holding AG (YPSN)
P/B ratio as of 2026 TTM: 0
According to Ypsomed Holding AG latest financial reports and stock price the company's current price-to-book ratio (TTM) is 0. At the end of 2026 the company had a P/B ratio of 0.
P/B ratio history for Ypsomed Holding AG from 2002 to 2026
P/B ratio at the end of each year
| Year | P/B Ratio | Change |
|---|---|---|
| 2025 | 6.82 | -13.09% |
| 2024 | 7.85 | 70.89% |
| 2023 | 4.59 | -12.56% |
| 2022 | 5.25 | 3.79% |
| 2021 | 5.06 | 20.48% |
| 2020 | 4.20 | -2.01% |
| 2019 | 4.29 | -20.06% |
| 2018 | 5.36 | -32.47% |
| 2017 | 7.94 | 22.85% |
| 2016 | 6.46 | 35.61% |
| 2015 | 4.76 | 10.83% |
| 2014 | 4.30 | 37.37% |
| 2013 | 3.13 | -1.57% |
| 2012 | 3.18 | 137.79% |
| 2011 | 1.34 | -11.70% |
| 2010 | 1.51 | -16.97% |
| 2009 | 1.82 | -20.20% |
| 2008 | 2.29 | -16.71% |
| 2007 | 2.74 | -51.05% |
| 2006 | 5.61 | 55.49% |
| 2005 | 3.61 | -77.17% |
| 2004 | 15.79 | 840.63% |
| 2003 | 1.68 | -80.98% |
| 2002 | 8.82 | 0.00% |
P/B ratio for similar companies or competitors
| Company | P/B Ratio | P/B Ratio Difference | Country |
|---|---|---|---|
| 2.9423 | - |
IE
|
|
| 4.1622 | - |
CN
|
|
| - | - |
CH
|
|
| 3.3974 | - |
CN
|
|
| 1.7328 | - |
KR
|
